Daiwa Securities Group Inc. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
300.0%0.00%
Q2 2023$10.0%300.0%0.00%
Q1 2023$10.0%300.0%0.00%
Q4 2022$1
-99.9%
300.0%0.00%
Q3 2022$1,0000.0%300.0%0.00%
Q2 2022$1,0000.0%300.0%0.00%
Q1 2022$1,000
-50.0%
300.0%0.00%
Q4 2021$2,0000.0%300.0%0.00%
Q3 2021$2,000
+100.0%
300.0%0.00%
Q2 2021$1,0000.0%300.0%0.00%
Q1 2021$1,0000.0%300.0%0.00%
Q4 2020$1,000
-66.7%
30
-63.4%
0.00%
Q3 2020$3,000
-25.0%
820.0%0.00%
Q2 2020$4,0000.0%820.0%0.00%
Q1 2020$4,000
-20.0%
820.0%0.00%
Q4 2019$5,0000.0%820.0%0.00%
Q3 2019$5,0000.0%820.0%0.00%
Q2 2019$5,000
+25.0%
820.0%0.00%
Q1 2019$4,000
+33.3%
820.0%0.00%
Q4 2018$3,000
-50.0%
820.0%0.00%
Q3 2018$6,0000.0%820.0%0.00%
Q2 2018$6,000
+50.0%
820.0%0.00%
Q1 2018$4,000820.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 94,922$4,063,0001.33%
Smith, Graham & Co., Investment Advisors, LP 277,572$11,880,0001.05%
Krensavage Asset Management, LLC 70,804$3,030,0001.03%
BRANDES INVESTMENT PARTNERS, LP 716,873$30,682,0000.68%
GLOBEFLEX CAPITAL L P 42,357$1,813,0000.33%
Zebra Capital Management LLC 6,472$277,0000.32%
Capital Impact Advisors, LLC 19,276$825,0000.27%
Hein Park Capital Management LP 31,977$1,369,0000.26%
CHARTWELL INVESTMENT PARTNERS, LLC 195,340$8,361,0000.25%
Stanley-Laman Group, Ltd. 24,000$1,027,0000.15%
View complete list of EAGLE PHARMACEUTICALS INC shareholders